Boule Diagnostics AB Share Price

Equities

BOUL

SE0011231158

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm 15:47:57 29/04/2024 BST 5-day change 1st Jan Change
10.15 SEK +3.57% Intraday chart for Boule Diagnostics AB +3.95% -10.87%

Financials

Sales 2024 * 580M 53.02M 4.23B Sales 2025 * 620M 56.72M 4.53B Capitalization 381M 34.8M 2.78B
Net income 2024 * 28M 2.56M 205M Net income 2025 * 41M 3.75M 299M EV / Sales 2024 * 0.79 x
Net Debt 2024 * 77.93M 7.13M 569M Net Debt 2025 * 75.63M 6.92M 552M EV / Sales 2025 * 0.74 x
P/E ratio 2024 *
13.2 x
P/E ratio 2025 *
9.09 x
Employees 228
Yield 2024 *
2.09%
Yield 2025 *
3.47%
Free-Float 61.67%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.43%
1 week+3.95%
Current month+0.70%
1 month+1.63%
3 months-12.89%
6 months+8.70%
Current year-10.87%
More quotes
1 week
9.28
Extreme 9.28
10.20
1 month
9.14
Extreme 9.14
10.20
Current year
9.05
Extreme 9.05
12.62
1 year
8.66
Extreme 8.66
12.78
3 years
8.66
Extreme 8.66
67.00
5 years
8.66
Extreme 8.66
79.60
10 years
8.66
Extreme 8.66
108.88
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 12-31
Human Resources Officer - 30/09/22
Corporate Officer/Principal - 31/12/11
Members of the board TitleAgeSince
Chairman 71 31/12/20
Chairman 72 31/12/20
Director/Board Member 57 31/12/13
More insiders
Date Price Change Volume
29/04/24 10.15 +3.57% 41 120
26/04/24 9.8 +4.03% 39,281
25/04/24 9.42 -1.46% 19,433
24/04/24 9.56 -1.44% 1,521
23/04/24 9.7 +0.83% 2,928

Delayed Quote Nasdaq Stockholm, April 29, 2024 at 03:47 pm

More quotes
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
9.8 SEK
Average target price
10.4 SEK
Spread / Average Target
+6.12%
Consensus